BioAgilytix supplies its assay expertise to describe the appropriate analytical assays needed to determine and ensure that biosimilar critical quality parameters are on track.
In this article, Bioanalysis Zone explores the launch of BioAgilytix’s new range of customizable COVID-19 testing packages with commentary from leadership team members.
This article by Applied Clinical Trials explores BioAgilytix’s new customizable COVID-19 testing packages that include services to address sponsor needs stemming from the coronavirus pandemic.
WRAL TechWire lists BioAgilytix’s new COVID-19 testing packages as noteworthy technology news affecting the North Carolina ecosystem.
This article by Verdict Medical Devices explores BioAgilytix’s new customizable COVID-19 testing packages, which include return-to-work screening for employers and assays for clinical sponsors.
The Business Wire covers the launch of BioAgilytix’s customizable COVID-19 testing packages, which include services to address a breadth of sponsor and employer needs stemming from the coronavirus pandemic.
3rd Watch News lists BioAgilytix as a top, key player in its “COVID-19 Impact on Global Cell-based Assays Market Size, Status and Forecast 2020-2026.”
The Derrick explores BioAgilytix’s new customizable COVID-19 testing packages with services to address a breadth of sponsor and employer needs stemming from the coronavirus pandemic.
PRNewswire covers BioAgilytix’s listing on The “Bioanalytical Testing Services Market by Type, Application, End User – Global Forecasts to 2025 ” report that was added to ResearchAndMarkets.com’s offering.
In a contributed article published by Biocompare, Dr. Corinna Fiorotti of BioAgilytix discusses how CAR T-cell therapies are making major headway and can be bioanalytically supported.
Services
Platforms